FDA Warning Letter — HomeChoice Partners dba BioScript Infusion Services

Case 606962 — FEI 3014461693

The FDA took a Warning Letter action against HomeChoice Partners dba BioScript Infusion Services on April 9, 2020 (Augusta, GA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
HomeChoice Partners dba BioScript Infusion Services
Date
April 9, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Augusta, GA (United States)